الرئيسية
استكشاف
nav.journalClub
الرائج
المزيد
synapse
⌘+K
اللغة
العربية
Cutaneous Toxicities of Small Molecules in Targeted Cancer Therapy Part II – Approach to Management and Treatment | Synapse
March 3, 2026
Cutaneous Toxicities of Small Molecules in Targeted Cancer Therapy Part II – Approach to Management and Treatment
IN
Ian Nykaza
Memorial Sloan Kettering Cancer Center
BK
Bernice Y. Kwong
Palo Alto University
AG
Allison Gordon
Memorial Sloan Kettering Cancer Center
Key Points
Management strategies for cutaneous toxicities are essential in targeted cancer therapy.
Key interventions include topical agents and dose adjustments, alongside monitoring.
Guidelines provide a comprehensive approach to managing cutaneous toxicities effectively.
Improvements in patient quality of life rely on effective management of these toxicities.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Nykaza et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75f74c6e9836116a2ad70
https://doi.org/https://doi.org/10.1016/j.jaad.2025.11.106